NASDAQ · STOCK
Thermo Fisher Scientific
$526.95
52W $403.36 – $643.99
61/100
$194.99B
28.2
0.86
Price History (6M)
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Executive Summary
7 analysts weighed in with 43% agreement on a bullish lean. Portfolio Manager: Portfolio position concentration is currently healthy. Value Analyst: P/E of 28.6 is moderate-to-rich. Overall recommendation: WATCH.
Bull & Bear Case
Bull Case
- Positive MACD histogram signals bullish momentum.
- Weekly trend: uptrend.
- Daily downtrend but weekly uptrend — possible early reversal but not yet confirmed on the daily.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- Risk/reward is unfavorable: 6.2% downside vs 2.2% upside.
AI Investment Committee
Committee Consensus
As of July 11, 2026
Overall Committee Score
61/100
Agreement
50%
Analysts
6
Conviction
Contested
Value Analyst
bearish
35
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 28.6 is moderate-to-rich
Growth Analyst
neutral
52
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ 4 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 19.0% signals elevated volatility
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
68
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.33 across 28 articles, 14d)
Portfolio Manager
bullish
75
/ 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Technical Analysis
RSI (14)
69.3
Neutral
MACD Histogram
2.789
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$494.22
Resistance
$538.40
Bollinger %B
0.84
Inside Bands
Price vs Moving Averages
EMA 9
$514.47
Above
EMA 21
$500.91
Above
EMA 50
$490.87
Above
EMA 200
$505.56
Above
Fundamental Analysis
Valuation
54
Growth
46
Profitability
65
Financial Health
89
Valuation
P/E Ratio
28.2×
P/B Ratio
4.08×
PEG Ratio
—
Dividend Yield
0.36%
52W High
$643.99
52W Low
$403.36
Quality & Growth
ROE
1324.0%
ROA
640.0%
Gross Margin
4089.0%
Operating Margin
1746.0%
Revenue Growth YoY
+536.0%
Debt / Equity
0.74
AI Fundamental Assessment
P/E ratio of 28.2 (moderate relative to a 15-40x range); Price-to-book of 4.1x; Revenue growth (YoY) of 5.4%; EPS growth (YoY) of 6.7%; Return on equity of 13.2%; Return on assets of 6.4%; Net margin of 15.2%; Gross margin of 40.9%; Current ratio of 1.89 (healthy short-term liquidity); Debt-to-equity of 0.74; Most recent quarter beat estimates by 2.8%; 4 consecutive earnings beats; EPS growth decelerating (+13.5% -> -17.2% QoQ); Analyst estimates falling over recent quarters
Key Risks
- Risk/reward is unfavorable: 6.2% downside vs 2.2% upside.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full TMO Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile